A novel Ir(III) complex 1 displays high selectivity for the Gquadruplex, and was used to establish a label-free Gquadruplex-based detection platform for lysozyme in buffer. In this study, we employed a special feature of most G-10
quadruplex probes, in that they do not respond towards the TBA G-quadruplex. A duplex DNA with a TBA Gquadruplex tail was designed for the detection of lysozyme. The presence of lysozyme will induce duplex dissociation and release the hybridized c-kit87 G-quadruplex, which would be 15 recognized by the Ir(III) complex to generate a strong luminescence response. Common duplex DNA designs lacking a TBA G-quadruplex tail typically contain long complementary DNA regions that may be too stable to be dissociated, thus decreasing sensitivity. We anticipate the 20 presence of TBA tail in the DNA duplex may destabilize the duplex structure, allowing the aptamer to more easily be dissociated and bind to the lysozyme, thereby increase the sensitivity of the lysozyme detection platform. To our knowledge, this is the first example of the use of the TBA G-25 quadruplex to improve sensitivity through fine-tuning duplex stability. We believe this approach may be further employed in sensing platforms for other targets. This assay exhibited a linear response for lysozyme within the concentration range of 2 to 50 nM (R 2 = 0.9904), and the limit of detection for 30 lysozyme was 2 nM. Moreover, this platform exhibited potential use for biological sample analysis.
Lysozyme, a 129 amino acid enzyme, exists universally in human body tissues and secretions. It has a molecular weight of approximately 14.3 kDa and an isoelectric point value of 11.0. 1, 2 35 Lysozyme protects humans from the ever-present danger of bacterial infection by destroying the protective cell walls of bacteria. 3, 4 The concentrations of lysozyme in serum, saliva, and urine have been used as clinical indicators for many diseases, such as, renal diseases, meningitis and leukemia. 5 Therefore, the 40 detection of lysozyme is of great importance in biochemical and biomedical fields.
The enzyme-linked immunosorbent assay (ELISA)-based assay is a commonly-used method in medical diagnostics and environmental analyses due to its high sensitivity and 45 specificity. 6, 7 However, the immunoassay method bears certain drawbacks, including the use of unstable antibodies, and timeconsuming and expensive protocols. 8, 9 However, DNA aptamers are much more stable under various conditions, and their binding abilities could be preserved upon a lot of denaturation-50 renaturation cycles 10 . The lysozyme DNA aptamer (5'-ATCAG 3 CTA 3 GAGTGCAGA GT 2 ACT 2 AG-3') specifically binds to lysozyme with a dissociation constant (K d ) of 31 nM. 11 The binding event between lysozyme and its aptamer is kept by a structural conversion of the DNA aptamer. This "structure-55 switching" issue of the lysozyme aptamer has been transformed into electrochemical, 12-17 luminescent, [18] [19] [20] [21] [22] [23] [24] [25] resonance Rayleighscattering, 26, 27 colorimetric, [28] [29] [30] [31] or signals in various lysozyme detection assays.
G-quadruplex (G4) DNA is a DNA secondary structure 60 formed by G-tetrad stacking which is supported by Hoogsteen hydrogen bonding and monovalent cations. 32 The rich structural polymorphism of G-quadruplex has rendered them as an useful signal transducers for the development of label-free detection probe for various analytes. [33] [34] [35] Meanwhile, transition metal 65 complexes have arisen as an important tool for biomolecules because of the long lifetime luminescence, large Stokes shift, easily to be synthesized and the tunable excitation and emission. Our group has previously reported that Ir(III) complexes can be utilized as a selective G-quadruplex DNA probes. 36, 37 In this 70 study, we sought to develop a label-free luminescent turn-on assay for the detection of lysozyme using the novel Ir(III) complex 1 [Ir 2 (Br-ppy) 4 Cl 2 ] (where Br-ppy = 2-(4bromophenyl)pyridine and biq = 2,2'-biquinoline) as a Gquadruplex probe. We employed a special feature of most G- 75 quadruplex probes, in that they do not respond towards the TBA G-quadruplex. A duplex DNA with a TBA G-quadruplex tail was designed for the detection of lysozyme. The presence of lysozyme will induce duplex dissociation and release the hybridized c-kit87 G-quadruplex, which would be recognized by the Ir(III) complex to generate a strong luminescence response. 5 Common duplex DNA designs lacking a TBA G-quadruplex tail typically contain long complementary DNA regions that may be too stable to be dissociated, thus decreasing sensitivity. We anticipate the presence of TBA tail in the DNA duplex may destabilize the duplex structure, allowing the aptamer to more 10 easily be dissociated and bind to the lysozyme, thereby increase the sensitivity of the lysozyme detection platform. To our knowledge, this is the first example of the use of the TBA Gquadruplex to improve sensitivity through fine-tuning duplex stability. We believe this approach may be further employed in 15 other sensing platforms for other targets. Ir(III) complex 1 carrying the Br-ppy as its C^N ligand and the biq as its N^N ligand, was used in the present study. The structure, emission and absorption spectra of complex 1 are presented in Fig. 1a, 1b and Table S1 . The maximum emission 20 wavelength 615 nm is phosphorescent in nature as revealed by with quantum yield = 0.195 and long emission lifetime (4.187 µs). Complex 1 was examined for its ability to identify Gquadruplex from dsDNA and ssDNA (Table S2 ). Complex 1 showed a superior specificity for G-quadruplex DNA, especially 25 towards the c-kit87 G-quadruplex DNA with a 5.5-fold change (Fig. 2a ), and exhibited an excellent discrimination with high values of I G4 /I ssDNA = 4.9 and I G4 /I dsDNA = 4.4 (Fig. 2b) . The c-kit87 G-quadruplex is one of the c-kit G-quadruplex sequences located in the promoter region of the human c-kit oncogene, 30 which is a potential therapeutic target for the treatment of gastrointestinal tumors due to its role in the development of mast cells, melanocytes and hematopoietic stem cells. Moreover, complex 1 shows no signal enhancement towards the thrombinbinding aptamer (TBA) G-quadruplex, which is a DNA aptamer 35 sequence that selectively binds to thrombin and fold into a Gquadruplex structure. TBA has previously been reported to prefer accommodate the planar aromatic compounds, but not ribbon-like compounds. It outlines that 1 may bind to G-quadruplex outside the G-tetrad region. In order to study if the loop plays the role in 40 the binding interaction, the response of complex 1 towards Gquadruplex with various loop size was investigated. The luminescence of 1 in the presence of various loop size of Gquadruplex, including sequences containing a 5′-side loop, a central loop or a 3′-side loop, with loop sizes ranging from 1 to 45 15 nucleotides (nt) were tested ( Fig. S1a-1c ). The results showed that the luminescence enhancement of complex 1 increased with increasing loop size no matter the site of loop. This result shows that the G-quadruplex loops involve in the binding interaction and the loop size could influence the binding interaction between 50 probes and G4 motif.
The strong binding of complex 1 towards c-kit87 Gquadruplex was further validated by G-quadruplex fluorescent intercalator displacement (G4-FID) experiments and FRETmelting assay experiments. The result displays that 5.2 µM 1 was 55 able to displace 50% thiazole orange (TO) in G-quadruplex. On the other hand, less than 50% of TO was displaced from dsDNA even at the highest concentrations of 1 added, (Fig. 3a) . In the presence of 1, the melting temperature (∆T m ) of the F21T Gquadruplex was increased by 7.5 °C, which is 12-fold higher than 60 that for F10T dsDNA (0.6 °C) at the same concentration of 1 (Fig. 3b and c) . These results indicate that complex 1 selectively bind to G-quadruplex over dsDNA or ssDNA.
The mechanism of the lysozyme detection is depicted in Fig.  4 .
The ON1 DNA (5′-65 GC 3 TC 3 TATCAG 3 CTA 3 GAGTGCAGAGT 2 ACT 2 AGAG 2 T 2 G 2 T GTG 2 T 2 G 2 -3′) containing the lysozyme aptamer and a TBA Gquadruplex structure, is initially hybridized with a partly complementary ON2 DNA (5′-C 2 TGATAG 3 AG 3 CGCTG 3 AG 2 AG 3 -3′) which contains a G-rich DNA sequence (c-kit87) to form a duplex substrate. In the presence of complex 1, this system exhibited a weak signal enhancement since the G-quadruplex probe complex 1 interacts 5 weakly with both the TBA G-quadruplex and duplex DNA. However, the addition of lysozyme causes ON1 dissociate from ON2 because of the binding of the lysozyme towards the lysozyme aptamer, allowing ON2 to fold into a G-quadruplex motif. This results a strong luminescent signal enhancement that 10 enables the system to function as a label free switch-on luminescent detection platform for lysozyme.
We initially studied the luminescence of 1 and the ON1/ON2 duplex to lysozyme in buffer. The luminescence intensity of 1 was significantly increased by the addition of lysozyme. To 15 confirm the enhanced luminescence came from the production of the lysozyme-induced G-quadruplex c-kit87, a series of control experiments were carried out. No significant increase in luminescence was observed when lysozyme was added to 1 in the absence of ON1/ON2, indicating that 1 did not interact with 20 lysozyme directly (Fig. S2) . We also prepared a dsDNA substrate (ON1 m , 5′-GT 2 CTT 2 CTATCAG 3 CTA 3 GAGTGCAGAGT 2 ACT 2 AGAG 2 T 2 G 2 TGTG 2 T 2 G 2 -3′; ON2 m , 5′-C 2 TGATAGA 2 AGA 2 CGCTGA 2 AG 2 AGA 2 -3′) that is unable to 25 fold into a G-quadruplex structure in the presence of lysozyme because of the absence of key guanine residues. As expected, only slight increase in the luminescence of 1 was recorded at 50 nM lysozyme for the mutant DNA substrate, indicating that the formation of the G-quadruplex motif is important for the 30 mechanism of this assay (Fig. S3 ). Taken together, these results indicate that the luminescence enhancement of the system originated from the specific interaction of complex 1 with the Gquadruplex motif.
To obtain a better sensitivity, concentrations of dsDNA and 35 complex 1 were optimized separately. The concentration of duplex DNA was optimal at 0.2 µM (Fig. S4a) , and the concentration of complex 1 was optimal at 1.5 µM (Fig. s4b) . The luminescence response of the system to different concentrations of lysozyme (2 to 500 nM) was then recorded. The system 40 displayed a ca. 4.3-fold enhancement in emission intensity at [lysozyme] = 500 nM (Fig. 5a) , with a linear range of detection from 2 to 50 nM (Fig. 5b) . The detection limit of this probe for lysozyme was calculated to be 1.96 nM by using the 3-sigma method. This detection limit is comparable to those of previously 45 reported aptamer-based luminescent methods for lysozyme detection (Table S3 ). For comparison, we performed the lysozyme detection platform utilizing a duplex DNA substrate without a TBA tail, and the detection limit was calculated to be 45.2 nM, which is ca. 23-fold higher than that for the system 50 containing a TBA tail. This result is consistent with our expectation that the presence of the TBA tail in the DNA duplex may destabilize the duplex structure, allowing the aptamer to be more easily dissociated and bind to lysozyme, thereby increasing the sensitivity of the lysozyme detection platform (Fig. S5) . 55 The specificity of this probe for lysozyme was examined by investigating the luminescence enhancement of complex 1 to different biomolecules such as thrombin, hemoglobin, bovine serum albumin, β-amyloid and ATP. As shown in Fig. 5 , only weak luminescence enhancements were observed upon addition 60 of 200 nM of thrombin, hemoglobin, BSA, β-amyloid and ATP. This result indicates that the detection platform is specific towards lysozyme over other various biomolecules.
To investigate the robustness of this detection system, we also studied the performance of complex 1 for the detection of 65 lysozyme in the presence of cellular debris. Encouragingly, complex 1 experienced an evenly increase in luminescence intensity as increasing concentration of lysozyme in the presence of 0.5% (v/v) cell extract ( Fig. 7a and Fig. 7b ). The result outlines that complex 1 could potentially be used as a sensitive lysozyme 70 detection platform for detecting lysozyme in biological sample.
In conclusion, the novel luminescent Ir(III) complex 1 has been found to show superior selectivity for G4 DNA (apart from the TBA G-quadruplex) over dsDNA and ssDNA, and was utilized to construct a label-free G-quadruplex-based detection 75 platform for lysozyme in aqueous solution. We employed a special feature of most G-quadruplex probes, in that they do not respond towards the TBA G-quadruplex. A duplex DNA with a TBA G-quadruplex tail was designed for the detection of lysozyme. The presence of lysozyme will induce duplex 80 dissociation and release the hybridized ckit87 G-quadruplex, which would be recognized by the Ir(III) complex to generate a strong luminescence response. Common duplex DNA designs lacking a TBA G-quadruplex tail typically contain long complementary DNA regions that may be too stable to be 85 dissociated, thus decreasing sensitivity. We anticipate the presence of TBA tail in the DNA duplex may destabilize the duplex structure, allowing the aptamer to more easily be dissociated and bind to the lysozyme, thereby increase the sensitivity of the lysozyme detection platform. Moreover, this platform was highly selective for lysozyme detection over other 5 biomolecules. Complex 1 could monitor as low as 2 nM of lysozyme, which is comparable to other reported label-free Gquadruplex-based assays for lysozyme detection. This label-free G-quadruplex-based luminescence switch-on platform is simple, rapid and cost-effective compared to conventional antibody-based 10 assays. To our knowledge, this is the first example of the use of the TBA G-quadruplex to improve sensitivity through fine-tuning duplex stability. We believe this approach may be further employed in other sensing platforms for other targets. 
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